Biotetch company opens 245,000 square-foot facility in Bay Area

  • 📰 sfexaminer
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 63%

Business News News

Business Business Latest News,Business Business Headlines

.Amgen signed their South San Francisco lease nearly three years ago. Its site will focus on the development of medicines in three core treatment areas: cancer, inflammatory disease and cardiometabolic disorders.

Amgen, the biopharmaceutical company, is opening its second-largest research and development facility in South San Francisco's Oyster Point, representing a significant pharma footprint in the Bay Area.

At nine-stories tall, the 245,000-square-foot facility will house 650 employees across 24 functions. The site also features open work spaces and modular labs, structures that are created with as many moveable furnishings as possible. These design choices are meant to encourage greater collaboration and teamwork.

Pour one out: Popular Tenderloin gastropub shuts down San Francisco outpost offered beer from"on-the-fly" taps The facility's opening was slightly delayed, as Amgen originally hoped to open their doors earlier this year. A company spokesperson said Amgen was not disclosing costs associated with the facility.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 236. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines